{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Parkinson\u2019s disease", "europinidin", "oxidative stress", "rotenone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36363986", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "23"}], "Language": ["eng"], "ELocationID": ["7159", "10.3390/molecules27217159"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "21", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "23"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Europinidin Inhibits Rotenone-Activated Parkinson's Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways.", "Abstract": {"AbstractText": ["Background: Europinidin is a derivative of delphinidin obtained from the plants Plumbago Europea and Ceratostigma plumbaginoides. This herb has wide medicinal applications in treating various diseases but there are very few studies available on this bioactive compound. Considering this background, the present study is designed for the evaluation of Europinidin against Parkinson\u2019s disease. Aim: The investigation aims to assess the effect of Europinidin in the rotenone-activated Parkinson\u2019s paradigm. Methods: To evaluate neuroprotective activity, rotenone (1.5 mg/kg s.c) and europinidin (10 mg/kg and 20 mg/kg) was administered in rats for 21 days. The behavioural parameters were performed before sacrificing the rats. On the 22nd day, all the rats were assessed for biochemical markers (SOD, GSH, MDA, Catalase), neurotransmitter levels (Dopamine, 5-HIAA, DOPAC, and HVA levels), and neuroinflammatory markers (IL-6, IL-1\u03b2 and TNF-\u03b1). Results: It was found that rotenone produced significant (p < 0.001) oxidative damage, a cholinergic deficit, dopaminergic loss, and a rise in neuroinflammatory markers in rats. Conclusion: The study concludes that europinidin possesses anti-oxidant and anti-inflammatory properties. The results suggest the therapeutic role of europinidin against rotenone-activated behavioural, biochemical, and neuroinflammatory alterations in rats."]}, "AuthorList": [{"Identifier": ["0000-0002-6491-6611"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Altharawi", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Alharthy", "ForeName": "Khalid M", "Initials": "KM"}, {"Identifier": ["0000-0003-3548-0852"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Althurwi", "ForeName": "Hassan N", "Initials": "HN"}, {"Identifier": ["0000-0001-9343-5713"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Albaqami", "ForeName": "Faisal F", "Initials": "FF"}, {"Identifier": ["0000-0003-4007-4023"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmacy, Jouf University, Aljouf, Sakaka 72341, Saudi Arabia."}], "LastName": "Alzarea", "ForeName": "Sami I", "Initials": "SI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Al-Abbasi", "ForeName": "Fahad A", "Initials": "FA"}, {"Identifier": ["0000-0003-4112-0925"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Nadeem", "ForeName": "Muhammad Shahid", "Initials": "MS"}, {"Identifier": ["0000-0003-1881-5219"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Kazmi", "ForeName": "Imran", "Initials": "I"}], "GrantList": [{"GrantID": "IF-PSAU-2021/03/18363", "Agency": "Ministry of Education, Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "03L9OT429T", "NameOfSubstance": "Rotenone"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "VTD58H1Z2X", "NameOfSubstance": "Dopamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rotenone"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": [], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Rodentia"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dopamine"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Shimohama S., Sawada H., Kitamura Y., Taniguchi T. Disease model: Parkinson\u2019s disease. Trends Mol. Med. 2003;9:360\u2013365. doi: 10.1016/S1471-4914(03)00117-5.", "ArticleIdList": ["10.1016/S1471-4914(03)00117-5", "12928038"]}, {"Citation": "Long-Smith C.M., Sullivan A.M., Nolan Y.M. The influence of microglia on the pathogenesis of Parkinson\u2019s disease. Prog. Neurobiol. 2009;89:277\u2013287. doi: 10.1016/j.pneurobio.2009.08.001.", "ArticleIdList": ["10.1016/j.pneurobio.2009.08.001", "19686799"]}, {"Citation": "Spillantini M.G., Schmidt M.L., Lee V.M.Y., Trojanowski J.Q., Jakes R., Goedert M. \u03b1-Synuclein in Lewy bodies. Nature. 1997;388:839\u2013840. doi: 10.1038/42166.", "ArticleIdList": ["10.1038/42166", "9278044"]}, {"Citation": "Cui H., Kong Y., Zhang H. Oxidative Stress, Mitochondrial Dysfunction, and Aging. J. Signal Transduct. 2012;2012:646354. doi: 10.1155/2012/646354.", "ArticleIdList": ["10.1155/2012/646354", "PMC3184498", "21977319"]}, {"Citation": "Goldman S.M. Environmental Toxins and Parkinson\u2019s Disease. Annu. Rev. Pharmacol. Toxicol. 2014;54:141\u2013164. doi: 10.1146/annurev-pharmtox-011613-135937.", "ArticleIdList": ["10.1146/annurev-pharmtox-011613-135937", "24050700"]}, {"Citation": "Marey-Semper I., Gelman M., Levi-Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 1995;15:5912\u20135918. doi: 10.1523/JNEUROSCI.15-09-05912.1995.", "ArticleIdList": ["10.1523/JNEUROSCI.15-09-05912.1995", "PMC6577653", "7666176"]}, {"Citation": "Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat. Neurosci. 2000;3:1301\u20131306. doi: 10.1038/81834.", "ArticleIdList": ["10.1038/81834", "11100151"]}, {"Citation": "Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial Complex I Deficiency in Parkinson\u2019s Disease. J. Neurochem. 1990;54:823\u2013827. doi: 10.1111/j.1471-4159.1990.tb02325.x.", "ArticleIdList": ["10.1111/j.1471-4159.1990.tb02325.x", "2154550"]}, {"Citation": "Moreira C.G., Barbiero J.K., Ariza D., Dombrowski P.A., Sabioni P., Bortolanza M., Cunha C.D., Vital M.A., Lima M. Behavioral, Neurochemical and Histological Alterations Promoted by Bilateral Intranigral Rotenone Administration: A New Approach for an Old Neurotoxin. Neurotox. Res. 2012;21:291\u2013301. doi: 10.1007/s12640-011-9278-3.", "ArticleIdList": ["10.1007/s12640-011-9278-3", "21953489"]}, {"Citation": "Santiago R.M., Barbieiro J., Lima M.M.S., Dombrowski P.A., Andreatini R., Vital M.A.B.F. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2010;34:1104\u20131114. doi: 10.1016/j.pnpbp.2010.06.004.", "ArticleIdList": ["10.1016/j.pnpbp.2010.06.004", "20547199"]}, {"Citation": "Stoker T.B., Barker R.A. Recent developments in the treatment of Parkinson\u2019s Disease. F1000Research. 2020;9:1\u201312. doi: 10.12688/f1000research.25634.1.", "ArticleIdList": ["10.12688/f1000research.25634.1", "PMC7400683", "32789002"]}, {"Citation": "Harborne J.B. Comparative biochemistry of the flavonoids-IV.: Correlations between chemistry, pollen morphology and systematics in the family plumbaginaceae. Phytochemistry. 1967;6:1415\u20131428. doi: 10.1016/S0031-9422(00)82884-8.", "ArticleIdList": ["10.1016/S0031-9422(00)82884-8"]}, {"Citation": "Jaradat N.A., Al-Ramahi R., Zaid A.N., Ayesh O.I., Eid A.M. Ethnopharmacological survey of herbal remedies used for treatment of various types of cancer and their methods of preparations in the West Bank-Palestine. BMC Complement. Altern. Med. 2016;16:93. doi: 10.1186/s12906-016-1070-8.", "ArticleIdList": ["10.1186/s12906-016-1070-8", "PMC4784411", "26955822"]}, {"Citation": "Sezik E., Ye\u015filada E., Honda G., Takaishi Y., Takeda Y., Tanaka T. Traditional medicine in Turkey, X. Folk medicine in Central Anatolia. J. Ethnopharmacol. 2001;75:95\u2013115. doi: 10.1016/S0378-8741(00)00399-8.", "ArticleIdList": ["10.1016/S0378-8741(00)00399-8", "11297840"]}, {"Citation": "Beigmohamadi M., Movafeghi A., Sharafi A., Jafari S., Danafar H. Cell Suspension Culture of Plumbago europaea L. Towards Production of Plumbagin. Iran. J. Biotechnol. 2019;17:46\u201354. doi: 10.21859/ijb.2169.", "ArticleIdList": ["10.21859/ijb.2169", "PMC6697843", "31457059"]}, {"Citation": "Issa M.Y., Ezzat M.I., Sayed R.H., Elbaz E.M., Omar F.A., Mohsen E. Neuroprotective effects of Pulicaria undulata essential oil in rotenone model of parkinson\u2019s disease in rats: Insights into its anti-inflammatory and anti-oxidant effects. S. Afr. J. Bot. 2020;132:289\u2013298. doi: 10.1016/j.sajb.2020.04.032.", "ArticleIdList": ["10.1016/j.sajb.2020.04.032"]}, {"Citation": "Kandil E.A., Abdelkader N.F., El-Sayeh B.M., Saleh S. Imipramine and amitriptyline ameliorate the rotenone model of Parkinson\u2019s disease in rats. Neuroscience. 2016;332:26\u201337. doi: 10.1016/j.neuroscience.2016.06.040.", "ArticleIdList": ["10.1016/j.neuroscience.2016.06.040", "27365173"]}, {"Citation": "Rahhal B., Jaradat N., Shraim W.B.M., Zyoud A., Hattab S. The Diuretic Activity of Ephedra alata and Plumbago europaea in Mice using an Aqueous Extract. Moroc. J. Chem. 2018;6:6\u2013576. doi: 10.48317/IMIST.PRSM/morjchem-v6i4.12494.", "ArticleIdList": ["10.48317/IMIST.PRSM/morjchem-v6i4.12494"]}, {"Citation": "Afzal M., Alzarea S.I., Alharbi K.S., Alzarea A.I., Alenezi S.K., Alshammari M.S., Alquraini A.H., Kazmi I. Rosiridin Attenuates Scopolamine-Induced Cognitive Impairments in Rats via Inhibition of Oxidative and Nitrative Stress Leaded Caspase-3/9 and TNF-\u03b1 Signaling Pathways. Molecules. 2022;27:5888. doi: 10.3390/molecules27185888.", "ArticleIdList": ["10.3390/molecules27185888", "PMC9502378", "36144623"]}, {"Citation": "Gilani S.J., Bin-Jumah M.N., Al-Abbasi F.A., Nadeem M.S., Alzarea S.I., Ahmed M.M., Sayyed N., Kazmi I. Rosinidin Protects against Cisplatin-Induced Nephrotoxicity via Subsiding Proinflammatory and Oxidative Stress Biomarkers in Rats. Int. J. Environ. Res. Public Health. 2022;19:9719. doi: 10.3390/ijerph19159719.", "ArticleIdList": ["10.3390/ijerph19159719", "PMC9368304", "35955076"]}, {"Citation": "Muhammad Afzal K.A., Alenezi S., Alshammari M., Alomar F., Kazmi I. Europinidin Enhances Healing through Modulating Antioxidant Processes in Experimentally Induced-Stomach Ulcer Condition. Int. J. Pharmacol. 2022;18:1509\u20131520. doi: 10.3923/ijp.2022.1509.1520.", "ArticleIdList": ["10.3923/ijp.2022.1509.1520"]}, {"Citation": "Dhanalakshmi C., Janakiraman U., Manivasagam T., Justin Thenmozhi A., Essa M.M., Kalandar A., Khan M.A.S., Guillemin G.J. Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson\u2019s Disease. Neurochem. Res. 2016;41:1899\u20131910. doi: 10.1007/s11064-016-1901-5.", "ArticleIdList": ["10.1007/s11064-016-1901-5", "27038927"]}, {"Citation": "Zhang L., Hao J., Zheng Y., Su R., Liao Y., Gong X., Liu L., Wang X. Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson\u2019s Disease. Aging Dis. 2018;9:590\u2013604. doi: 10.14336/AD.2017.0831.", "ArticleIdList": ["10.14336/AD.2017.0831", "PMC6065300", "30090649"]}, {"Citation": "Madiha S., Haider S. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: Assessment by social interaction test and sucrose preference test. Metab. Brain Dis. 2019;34:297\u2013308. doi: 10.1007/s11011-018-0352-x.", "ArticleIdList": ["10.1007/s11011-018-0352-x", "30506334"]}, {"Citation": "Sun C., Wang Y., Mo M., Song C., Wang X., Chen S., Liu Y. Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson\u2019s Disease Rat Model. BioMed Res. Int. 2019;2019:e6843265. doi: 10.1155/2019/6843265.", "ArticleIdList": ["10.1155/2019/6843265", "PMC6425343", "30949504"]}, {"Citation": "Zaitone S.A., Abo-Elmatty D.M., Elshazly S.M. Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats. Indian J. Pharmacol. 2012;44:774\u2013779. doi: 10.4103/0253-7613.103300.", "ArticleIdList": ["10.4103/0253-7613.103300", "PMC3523508", "23248410"]}, {"Citation": "Zaitone S.A., Ahmed E., Elsherbiny N.M., Mehanna E.T., El-Kherbetawy M.K., ElSayed M.H., Alshareef D.M., Moustafa Y.M. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson\u2019s disease therapy. Pharmacol. Rep. 2019;71:32\u201341. doi: 10.1016/j.pharep.2018.08.004.", "ArticleIdList": ["10.1016/j.pharep.2018.08.004", "30368226"]}, {"Citation": "Vorhees C.V., Williams M.T. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006;1:848\u2013858. doi: 10.1038/nprot.2006.116.", "ArticleIdList": ["10.1038/nprot.2006.116", "PMC2895266", "17406317"]}, {"Citation": "Baghcheghi Y., Hosseini M., Beheshti F., Salmani H., Anaeigoudari A. Thymoquinone reverses learning and memory impairments and brain tissue oxidative damage in hypothyroid juvenile rats. Arq. Neuropsiquiatr. 2018;76:32\u201340. doi: 10.1590/0004-282x20170182.", "ArticleIdList": ["10.1590/0004-282x20170182", "29364392"]}, {"Citation": "Abdel-Salam O.M.E., Youness E.R., Ahmed N.A., El-Toumy S.A., Souleman A.M., Shaffie N., Abouelfadl D.M. Bougainvillea spectabilis flowers extract protects against the rotenone-induced toxicity. Asian Pac. J. Trop. Med. 2017;10:478\u2013490. doi: 10.1016/j.apjtm.2017.05.013.", "ArticleIdList": ["10.1016/j.apjtm.2017.05.013", "28647186"]}, {"Citation": "Sedaghat R., Roghani M., Khalili M. Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model. Iran. J. Pharm. Res. IJPR. 2014;13:227\u2013234.", "ArticleIdList": ["PMC3985249", "24734075"]}, {"Citation": "Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959;82:70\u201377. doi: 10.1016/0003-9861(59)90090-6.", "ArticleIdList": ["10.1016/0003-9861(59)90090-6", "13650640"]}, {"Citation": "Tseng H.C., Wang M.H., Chang K.C., Soung H.S., Fang C.H., Lin Y.W., Li K.Y., Yang C.C., Tsai C.C. Protective Effect of (\u2212)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats. Neurotox. Res. 2020;37:669\u2013682. doi: 10.1007/s12640-019-00143-6.", "ArticleIdList": ["10.1007/s12640-019-00143-6", "31811588"]}, {"Citation": "Sharma N., Nehru B. Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study. Exp. Neurobiol. 2013;22:214\u2013223. doi: 10.5607/en.2013.22.3.214.", "ArticleIdList": ["10.5607/en.2013.22.3.214", "PMC3807008", "24167416"]}, {"Citation": "Ukeda H., Kawana D., Maeda S., Sawamura M. Spectrophotometric Assay for Superoxide Dismutase Based on the Reduction of Highly Water-soluble Tetrazolium Salts by Xanthine-Xanthine Oxidase. Biosci. Biotechnol. Biochem. 1999;63:485\u2013488. doi: 10.1271/bbb.63.485.", "ArticleIdList": ["10.1271/bbb.63.485", "27393255"]}, {"Citation": "Sharma N., Bafna P. Effect of Cynodon dactylon on rotenone induced Parkinson\u2019s disease. Orient. Pharm. Exp. Med. 2012;12:167\u2013175. doi: 10.1007/s13596-012-0075-1.", "ArticleIdList": ["10.1007/s13596-012-0075-1"]}, {"Citation": "G\u00f3th L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta. 1991;196:143\u2013151. doi: 10.1016/0009-8981(91)90067-M.", "ArticleIdList": ["10.1016/0009-8981(91)90067-M", "2029780"]}, {"Citation": "Danduga R.C.S.R., Dondapati S.R., Kola P.K., Grace L., Tadigiri R.V.B., Kanakaraju V.K. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats. Biomed. Pharmacother. 2018;105:1254\u20131268. doi: 10.1016/j.biopha.2018.06.079.", "ArticleIdList": ["10.1016/j.biopha.2018.06.079", "30021362"]}, {"Citation": "Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Salehi B., Sharifi-Rad J., Cappellini F., Reiner \u017d., Zorzan D., Imran M., Sener B., Kilic M., El-Shazly M., Fahmy N.M., et al. The therapeutic potential of anthocyanins: Current approaches based on their molecular mechanism of action. Front. Pharmacol. 2020;11:1300. doi: 10.3389/fphar.2020.01300.", "ArticleIdList": ["10.3389/fphar.2020.01300", "PMC7479177", "32982731"]}, {"Citation": "Siracusa R., Scuto M., Fusco R., Trovato A., Ontario M.L., Crea R., Di Paola R., Cuzzocrea S., Calabrese V. Anti-inflammatory and Anti-oxidant Activity of Hidrox\u00ae in Rotenone-Induced Parkinson\u2019s Disease in Mice. Antioxidants. 2020;9:824. doi: 10.3390/antiox9090824.", "ArticleIdList": ["10.3390/antiox9090824", "PMC7576486", "32899274"]}, {"Citation": "Sharma N., Jamwal S., Kumar P. Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats. Pathophysiology. 2016;23:123\u2013134. doi: 10.1016/j.pathophys.2016.03.002.", "ArticleIdList": ["10.1016/j.pathophys.2016.03.002", "26996500"]}, {"Citation": "Garabadu D., Agrawal N. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. NeuroMol. Med. 2020;22:314\u2013330. doi: 10.1007/s12017-019-08590-2.", "ArticleIdList": ["10.1007/s12017-019-08590-2", "31916219"]}, {"Citation": "Guo Z., Ruan Z., Zhang D., Liu X., Hou L., Wang Q. Rotenone impairs learning and memory in mice through microglia-mediated blood brain barrier disruption and neuronal apoptosis. Chemosphere. 2022;291:132982. doi: 10.1016/j.chemosphere.2021.132982.", "ArticleIdList": ["10.1016/j.chemosphere.2021.132982", "34822863"]}, {"Citation": "Ablat N., Lv D., Ren R., Xiaokaiti Y., Ma X., Zhao X., Sun Y., Lei H., Xu J., Ma Y., et al. Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson\u2019s Disease. Molecules. 2016;21:1107. doi: 10.3390/molecules21091107.", "ArticleIdList": ["10.3390/molecules21091107", "PMC6274364", "27563865"]}, {"Citation": "Khurana N., Gajbhiye A. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson\u2019s disease. NeuroToxicology. 2013;39:57\u201364. doi: 10.1016/j.neuro.2013.08.005.", "ArticleIdList": ["10.1016/j.neuro.2013.08.005", "23994302"]}, {"Citation": "Karuppagounder S.S., Madathil S.K., Pandey M., Haobam R., Rajamma U., Mohanakumar K.P. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson\u2019s disease in rats. Neuroscience. 2013;236:136\u2013148. doi: 10.1016/j.neuroscience.2013.01.032.", "ArticleIdList": ["10.1016/j.neuroscience.2013.01.032", "23357119"]}, {"Citation": "Rahimmi A., Khosrobakhsh F., Izadpanah E., Moloudi M.R., Hassanzadeh K. N-acetylcysteine prevents rotenone-induced Parkinson\u2019s disease in rat: An investigation into the interaction of parkin and Drp1 proteins. Brain Res. Bull. 2015;113:34\u201340. doi: 10.1016/j.brainresbull.2015.02.007.", "ArticleIdList": ["10.1016/j.brainresbull.2015.02.007", "25732239"]}, {"Citation": "Erba\u015f O., Y\u0131lmaz M., Ta\u015fk\u0131ran D. Levetiracetam attenuates rotenone-induced toxicity: A rat model of Parkinson\u2019s disease. Environ. Toxicol. Pharmacol. 2016;42:226\u2013230. doi: 10.1016/j.etap.2016.02.005.", "ArticleIdList": ["10.1016/j.etap.2016.02.005", "26896611"]}, {"Citation": "Mohapel P., Leanza G., Kokaia M., Lindvall O. Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol. Aging. 2005;26:939\u2013946. doi: 10.1016/j.neurobiolaging.2004.07.015.", "ArticleIdList": ["10.1016/j.neurobiolaging.2004.07.015", "15718053"]}, {"Citation": "Khadrawy Y.A., Salem A.M., El-Shamy K.A., Ahmed E.K., Fadl N.N., Hosny E.N. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson\u2019s Disease Induced by Rotenone. J. Diet. Suppl. 2017;14:553\u2013572. doi: 10.1080/19390211.2016.1275916.", "ArticleIdList": ["10.1080/19390211.2016.1275916", "28301304"]}, {"Citation": "Khatri D.K., Juvekar A.R. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson\u2019s disease. Pharmacol. Biochem. Behav. 2016;150\u2013151:39\u201347. doi: 10.1016/j.pbb.2016.09.002.", "ArticleIdList": ["10.1016/j.pbb.2016.09.002", "27619637"]}, {"Citation": "Kaur H., Chauhan S., Sandhir R. Protective Effect of Lycopene on Oxidative Stress and Cognitive Decline in Rotenone Induced Model of Parkinson\u2019s Disease. Neurochem. Res. 2011;36:1435\u20131443. doi: 10.1007/s11064-011-0469-3.", "ArticleIdList": ["10.1007/s11064-011-0469-3", "21484267"]}, {"Citation": "Guo J.D., Zhao X., Li Y., Li G.R., Liu X.L. Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (Review) Int. J. Mol. Med. 2018;41:1817\u20131825. doi: 10.3892/ijmm.2018.3406.", "ArticleIdList": ["10.3892/ijmm.2018.3406", "29393357"]}, {"Citation": "Hamed M., Aboul Naser A., Elbatanony M., El-Feky A., Matloub A., El-Rigal N., Khalil W. Therapeutic Potential of Citrus sinensis Peels Against Rotenone Induced Parkinsonism in Rats. Curr. Bioact. Compd. 2021;17:22\u201339. doi: 10.2174/1573407216999200918182514.", "ArticleIdList": ["10.2174/1573407216999200918182514"]}, {"Citation": "Zhao X., Kong D., Zhou Q., Wei G., Song J., Liang Y., Du G. Baicalein alleviates depression-like behavior in rotenone- induced Parkinson\u2019s disease model in mice through activating the BDNF/TrkB/CREB pathway. Biomed. Pharmacother. 2021;140:111556. doi: 10.1016/j.biopha.2021.111556.", "ArticleIdList": ["10.1016/j.biopha.2021.111556", "34087694"]}, {"Citation": "Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., Lucius R. Activation of microglia by human neuromelanin is NF-\u03baB-dependent and involves p38 mitogen-activated protein kinase: Implications for Parkinson\u2019s disease. FASEB J. 2003;17:1\u201320. doi: 10.1096/fj.02-0314fje.", "ArticleIdList": ["10.1096/fj.02-0314fje", "12631585"]}, {"Citation": "Anusha C., Sumathi T., Joseph L.D. Protective role of apigenin on rotenone induced rat model of Parkinson\u2019s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. Chem. Biol. Interact. 2017;269:67\u201379. doi: 10.1016/j.cbi.2017.03.016.", "ArticleIdList": ["10.1016/j.cbi.2017.03.016", "28389404"]}, {"Citation": "Javed H., Meeran M.F.N., Azimullah S., Bader Eddin L., Dwivedi V.D., Jha N.K., Ojha S. \u03b1-Bisabolol, a Dietary Bioactive Phytochemical Attenuates Dopaminergic Neurodegeneration through Modulation of Oxidative Stress, Neuroinflammation and Apoptosis in Rotenone-Induced Rat Model of Parkinson\u2019s Disease. Biomolecules. 2020;10:1421. doi: 10.3390/biom10101421.", "ArticleIdList": ["10.3390/biom10101421", "PMC7599960", "33049992"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "8"}, {"Year": "2022", "Month": "10", "Day": "17"}, {"Year": "2022", "Month": "10", "Day": "20"}, {"Year": "2022", "Month": "11", "Day": "11", "Hour": "1", "Minute": "39"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["36363986", "PMC9658735", "10.3390/molecules27217159", "molecules27217159"]}}], "PubmedBookArticle": []}